Live from the NIH registry
Studies recruiting near Peoria right now
Top 25 of 217 recruiting studies, sorted by proximity — each links to its official registry page
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma
Phase 3
Interventional 804 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Narcolepsy Type 1, Narcolepsy Type 2
Phase 2, Phase 3
Interventional 786 participants sought
Alkermes Investigational Site — Peoria, Illinois (4.3 mi)
· Sponsor: Alkermes, Inc.
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Illinois Cancer Care — Peoria, Illinois (4.3 mi)
· Sponsor: SCRI Development Innovations, LLC
Improving Safety, Patient Experience and Equity Through Shared Decision-making Huddles in Labor
Perinatal Decision Making
N/A
Interventional 2,200 participants sought
OSF St. Francis Medical Center — Peoria, Illinois (4.3 mi)
· Sponsor: Endeavor Health
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — Peoria, Illinois (4.3 mi)
· Sponsor: Daiichi Sankyo
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
OSF Children's Hospital of Illinois — Peoria, Illinois (4.3 mi)
· Sponsor: Children's Oncology Group
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Colorectal Neoplasms
Phase 3
Interventional 1,000 participants sought
Illinois CancerCare — Peoria, Illinois (4.3 mi)
· Sponsor: Janssen Research & Development, LLC
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)
Lower Extremity Acute Limb Ischemia, LE ALI
N/A
Observational 300 participants sought
OSF Saint Francis Medical Center — Peoria, Illinois (4.3 mi)
· Sponsor: Penumbra Inc.
I-DECIDE After Bronchiolitis Hospitalization
Bronchiolitis Acute
N/A
Interventional 2,700 participants sought
OSF Children's Hospital of Illinois — Peoria, Illinois (4.3 mi)
· Sponsor: Seattle Children's Hospital
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Lung Non-Small Cell Carcinoma
Phase 3
Interventional 336 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: National Cancer Institute (NCI)
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Phase 3
Interventional 364 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: SWOG Cancer Research Network
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart Failure, Acute Heart Failure
Phase 3
Interventional 5,200 participants sought
Peoria, IL Investigative Site 10019 — Peoria, Illinois (4.3 mi)
· Sponsor: Colorado Prevention Center
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Illinois Cancer Care ( Site 7005) — Peoria, Illinois (4.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
OSF Children's Hospital of Illinois — Peoria, Illinois (4.3 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Multiple conditions
Phase 2
Interventional 98 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: NRG Oncology
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Cervical Cancer
Phase 4
Interventional 100 participants sought
Illinois Eye Center — Peoria, Illinois (4.3 mi)
· Sponsor: Pfizer
Pounce™ Thrombectomy System Retrospective Registry
Peripheral Arterial Disease, Acute Limb Ischemia
N/A
Observational 500 participants sought
OSF St. Francis Medical Center — Peoria, Illinois (4.3 mi)
· Sponsor: SurModics, Inc.
A Study of BG-C477 in Participants With Advanced Solid Tumors
Advanced Solid Tumors
Phase 1
Interventional 310 participants sought
Osf Saint Francis Medical Center — Peoria, Illinois (4.3 mi)
· Sponsor: BeOne Medicines
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 2
Interventional 474 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Phase 3
Interventional 255 participants sought
OSF Saint Francis Medical Center — Peoria, Illinois (4.3 mi)
· Sponsor: National Cancer Institute (NCI)
Stress Hydrocortisone In Pediatric Septic Shock
Septic Shock
Phase 3
Interventional 500 participants sought
The University of Illinois at Chicago/OSF Children's Hospital of Illinois — Peoria, Illinois (4.3 mi)
· Sponsor: Jerry Zimmerman
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma
Phase 2, Phase 3
Interventional 992 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: National Cancer Institute (NCI)
Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
Pancreatic Carcinoma
N/A
Observational 30,000 participants sought
OSF Saint Francis Medical Center — Peoria, Illinois (4.3 mi)
· Sponsor: Mayo Clinic